Wordt geladen...
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
INTRODUCTION: Cancer-directed immunotherapies are transforming the landscape in oncology as new and exciting therapies move from the laboratory to the bedside. Chimeric antigen receptor T (CAR-T) cells are one of these novel therapies, demonstrating impressive efficacy against B-cell malignancies. W...
Bewaard in:
| Gepubliceerd in: | Expert Rev Clin Immunol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7936577/ https://ncbi.nlm.nih.gov/pubmed/31219357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2019.1629904 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|